Bisphosphonates and ELD "EdirolTablet "
Phase 2Small molecule
Bisphosphonates and ELD "EdirolTablet " is one of 37 small molecule programs targeting Osteoporosis. It is currently in Phase 2.
1
Indications
1
Total Trials
1
Active Trials
36
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
172 competitors in Osteoporosis
#DrugCompanyPhaseTrials
1Boniva
CConrado Roberto Hoffmann Filho
Phase 3
Actonel
VVitae Pharmaceuticals Inc., an Allergan affiliate
Phase 3
One-Alpha
RochePhase 3
Livial
PfizerPhase 3
Depo-Provera
Eli LillyPhase 3
Tymlos
RRadius Health, Inc.
Phase 3
Glucophage
EMD SeronoPhase 3
Oxycodone IR
Johnson & JohnsonPhase 3
Bazedoxifene Acetate
PfizerPhase 3
Ibandronic Acid
RochePhase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 2[1]
- Company
- SShinshu University